US · USD
STLNW
Starling Oncology, Inc.
$0.040.00% ($0.00)
- Day's range
- $0.04 – $0.04
- Day's volume
- $365
- 52-week range
- $0.04 – $0.04
Follow STLNW in the Fuolio
See how STLNW weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountSTLNW in numbers
- Market cap
- $4M
- P/E
- 0.00
- P/B
- -0.16
- Dividend yield (12m)
- 0.00%
STLNW trades at 0.00 times its earnings of the last 12 months.
STLNW price history
STLNW changed 0.00% over 1Y.
Compare with
STLNW fundamentals
Valuation
- P/E0.00
- P/B-0.16
- EV/EBITDA-4.35
- EV/EBIT-3.21
- EV/Revenue0.14
- P/EBIT-0.15
- P/S0.01
- P/OCF12.06
- P/FCF-1.20
- Earnings yield-31.13%
- PEG ratio—
- Earnings per share$594.90
- Book value per share-$0.24
Debt
- Net debt$79.9M
- Net debt/EBITDA—
- Net debt/Equity-3.21
- Debt/Equity-3.21
- Current ratio1.36
- Quick ratio1.15
- Cash ratio—
Efficiency
- Gross margin—
- EBITDA margin-3.28%
- Operating margin-4.44%
- Net margin10,324.55%
- Asset turnover3.29
Profitability
- ROE-243,358.40%
- ROA34,017.45%
- ROIC-47.48%
- Payout0.00%
STLNW's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Earnings per share | $613.18 | $853.60 | -$1.12 | $0.00 | -$0.15 | — |
| Book value per share | -$0.16 | $0.05 | $0.77 | $1.65 | $1.42 | — |
| ROE | -385,534.35% | 1,801,699.64% | -145.67% | 0.12% | -10.49% | -50.97% |
| ROIC | -58.37% | -62.16% | -81.48% | -0.00% | -41.41% | -20.25% |
| EBITDA margin | -5.80% | -13.68% | -21.94% | -30.71% | -20.94% | -2.68% |
| Net margin | 12,055.40% | 16,436.46% | -25.62% | 0.06% | -5.38% | -7.64% |
STLNW's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $502.7M | $393.4M | $324.2M | $252.5M | $203M | $187.5M |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | -$29.1M | -$53.8M | -$71.1M | -$77.5M | -$42.5M | -$5M |
| EBIT | -$36.1M | -$60.1M | -$77M | -$82M | -$45.9M | -$8.2M |
| Financial result | -$24.7M | -$4.5M | -$6.1M | $81.9M | $34.3M | -$6.6M |
| Income before tax | -$60.7M | -$64.7M | -$83.1M | -$91K | -$11.6M | -$14.8M |
| Income tax | $131K | -$0 | $36K | $243K | $671K | $493K |
| Net income | $60.6B | $64.7B | -$83.1M | $152K | -$10.9M | -$14.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does STLNW pay dividends?
STLNW has no distributions on record.
About Starling Oncology
- Sector
- Services
Questions about STLNW
How much is STLNW today?
STLNW is at $0.04 (0.00% on the day), last traded on 10/05/2026.
What are the P/E and P/B of STLNW?
STLNW trades at a P/E of 0.00 and a P/B of -0.16.